Prevalence of Helicobacter pylori Infection in Bariatric Surgery Patients.
Bariatric surgery
Gastritis
Helicobacter pylori
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
31
08
2021
accepted:
13
12
2021
revised:
08
12
2021
medline:
26
6
2023
pubmed:
19
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
To determine the rate of histology-proven Helicobacter pylori (HP) infection in patients undergoing bariatric surgery and to identify risk factors for HP infection. In a retrospective analysis, patients who underwent bariatric surgery with gastric resection in a single hospital between January 2004 and January 2019 were analyzed. For each patient, a surgical specimen was submitted for anatomopathological examination and analyzed for gastritis or other anomalies. When gastritis was present, HP infection was confirmed by the identification of curvilinear bacilli in conventional histology or by specific immunohistochemical detection of HP antigen. A total of 6388 specimens were available for review (4365 women, 2023 men) with a mean age of 44.9 ± 11.2 years and a mean body mass index (BMI) of 49.3 ± 8.2 kg/m The rate of histology-proven HP infection is low in patients with severe obesity who present for bariatric surgery and is associated with age.
Identifiants
pubmed: 37202576
doi: 10.1007/s11695-023-06638-8
pii: 10.1007/s11695-023-06638-8
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2132-2138Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–76.
doi: 10.1111/apt.14561
pubmed: 29430669
Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology [Internet] Elsevier. 2017;153(2):420–9.
Bouvard V, Baan R, Straif K, et al WHO international agency for research on cancer monograph working group. A review of human carcinogens--Part B: biological agents. Lancet Oncol [Internet]. 2009;10(4):321–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19350698
Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among US adults. Journals Gerontol - Ser A Biol Sci Med Sci. 2009;64(2):272–9.
doi: 10.1093/gerona/gln012
Naja F, Kreiger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol. 2007;21(8):501–6.
doi: 10.1155/2007/462804
pubmed: 17703249
pmcid: 2657974
Carabotti M, D’Ercole C, Iossa A, et al. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol. 2014;20(3):647–53.
doi: 10.3748/wjg.v20.i3.647
pubmed: 24574738
pmcid: 3921474
Erim T, Cruz-Correa MR, Szomstein S, et al. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg. 2008;32(9):2021–5.
doi: 10.1007/s00268-008-9608-7
pubmed: 18581170
Verma S, Sharma D, Kanwar P, et al. Prevalence of Helicobacter pylori infection in bariatric patients: a histologic assessment. Surg Obes Relat Dis Internet Elsevier. 2013;9(5):679–85. https://doi.org/10.1016/j.soard.2012.10.001 .
doi: 10.1016/j.soard.2012.10.001
Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci. 2009;54(6):1243–6.
doi: 10.1007/s10620-008-0485-6
pubmed: 18975090
Nweneka C V., Prentice AM. Helicobacter pylori infection and circulating ghrelin levels - a systematic review. BMC Gastroenterol [Internet]. BioMed Central Ltd; 2011;11(1):7. Available from: http://www.biomedcentral.com/1471-230X/11/7
Mantero P, Matus GS, Corti RE, et al. Helicobacter pylori and corpus gastric pathology are associated with lower serum ghrelin. World J Gastroenterol. 2018;24(3):397–407.
doi: 10.3748/wjg.v24.i3.397
pubmed: 29391762
pmcid: 5776401
Liew PL, Lee WJ, Lee YC, et al. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obes Surg. 2006;16(5):612–9.
doi: 10.1381/096089206776945002
pubmed: 16687031
Lender N, Talley NJ, Enck P, et al. Review article: Associations between Helicobacter pylori and obesity - an ecological study. Aliment Pharmacol Ther. 2014;40(1):24–31.
doi: 10.1111/apt.12790
pubmed: 24832176
Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71(2):298–306.
doi: 10.1017/S0029665112000158
pubmed: 22414338
pmcid: 4791086
Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75.
doi: 10.3945/an.115.010207
pubmed: 26773015
pmcid: 4717890
De Heredia FP, Gómez-Martínez S, Marcos A. Chronic and degenerative diseases: obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71(2):332–8.
doi: 10.1017/S0029665112000092
pubmed: 22429824
Batts KP, Ketover S, Kakar S, et al. Appropriate use of special stains for identifying Helicobacter pylori: recommendations from the Rodger C Haggitt Gastrointestinal Pathology Society. Am J Surg Pathol. 2013;37(11):12–22.
doi: 10.1097/PAS.0000000000000097
Pirlet C, Biertho L, Poirier P, et al. Comparison of short and long term cardiovascular outcomes after bariatric surgery in patients with vs without coronary artery disease. Am J Cardiol. 2020;125(1):40–7.
doi: 10.1016/j.amjcard.2019.09.041
pubmed: 31694775
Dixon MF, Genta RM, Yardley JH et al Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol [Internet]. 1996 Oct [cited 2019 May 15];20(10):1161–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8827022
Takwoingi Y, Low B, Best LM et al Non-invasive diagnostic tests for Helicobacter pylori infection . Cochrane Database Syst Rev. 2018;(3)
Atkinson NSS, Braden B. Helicobacter pylori infection: diagnostic strategies in primary diagnosis and after therapy. Dig Dis Sci Springer, US. 2016;61(1):19–24.
doi: 10.1007/s10620-015-3877-4
Mohammadian T, Ganji L. The diagnostic tests for detection of Helicobacter pylori infection. Monoclon Antib Immunodiagn Immunother. 2019;38(1):1–7.
doi: 10.1089/mab.2018.0032
pubmed: 30648911
Talebi Bezmin Abadi A. Diagnosis of Helicobacter pylori using invasive and noninvasive approaches. J Pathog [Internet]. 2018;2018:1–13. Available from: https://www.hindawi.com/journals/jpath/2018/9064952/
Archana Ramaswamy, MD; Edward Lin, DO; Bruce J. et al. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg 2004 vol 139 pp 1094 [Internet]. 2004; Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871953356&doi=10.1016%2FS0013-7006%2812%2970076-3&partnerID=40&md5=a7baad7b24eabb38afde620dc07e05e9
Madan AK, Speck KE, Hiler ML. Routine preoperative upper endoscopy for laparoscopic gastric bypass: is it necessary? Am Surg [Internet]. 2004 Aug [cited 2019 May 15];70(8):684–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15328800
Zhao Y, Li Y, Hu J, et al. The effect of Helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies. Dig Dis. 2020;38(4):261–8.
doi: 10.1159/000504086
pubmed: 32396919
Raghunath A, Hungin APS, Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326(7392):737.
doi: 10.1136/bmj.326.7392.737
pubmed: 12676842
pmcid: 152634
Scida S, Russo M, Miraglia C, et al. Relationship between helicobacter pylori infection and GERD. Acta Biomed. 2018;89(4):40–3.
pubmed: 30561416
Sharma V. Helicobacter pylori : does it add to risk of coronary artery disease. World J Cardiol. 2015;7(1):19.
doi: 10.4330/wjc.v7.i1.19
pubmed: 25632315
pmcid: 4306202
Yu XJ, Yang X, Feng L, et al. Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: a meta-analysis. Exp Ther Med. 2017;13(2):787–93.
doi: 10.3892/etm.2017.4028
pubmed: 28352367
pmcid: 5348668
Stahl JM, Malhotra S. Obesity surgery indications and contraindications [Internet]. StatPearls. StatPearls Publishing; 2019 [cited 2020 Dec 9]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30020657
Sato T, Ida T, Nakamura Y, et al Physiological roles of ghrelin on obesity. Obes Res Clin Pract [Internet]. Asia Oceania Assoc. for the Study of Obesity; 2014;8(5):e405–e413. Available from: https://doi.org/10.1016/j.orcp.2013.10.002
Makris MC, Alexandrou A, Papatsoutsos EG, et al. Ghrelin and obesity: identifying gaps and dispelling myths. A reappraisal In Vivo (Brooklyn). 2017;31(6):1047–50.
Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol Nature Publishing Group. 2017;13(6):338–51.
doi: 10.1038/nrendo.2016.222
Ko Y, Tang J, Sanagapalli S, et al. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms. Expert Opin Drug Saf [Internet]. Informa Healthcare; 2016;15(1):53–63. Available from: https://doi.org/10.1517/14740338.2016.1118050
Berstad AE, Hatlebakk JG, Maartmann-Moe H, et al. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut. 1997;41(6):740–7.
doi: 10.1136/gut.41.6.740
pubmed: 9462205
pmcid: 1891604
Li Z, Wu C, Li L et al. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis [Internet]. Saudi Journal of Gastroenterology. Medknow Publications; 2017 [cited 2020 Jul 4]. p. 222–228. Available from: /pmc/articles/PMC5539675/?report=abstract
Egger G, Dixon J. Beyond obesity and lifestyle: a review of 21st century chronic disease determinants. Biomed Res Int. 2014;2014
Graham H, White PCL. Social determinants and lifestyles: integrating environmental and public health perspectives. Public Health [Internet]. Elsevier Ltd; 2016;141:270–278. Available from: https://doi.org/10.1016/j.puhe.2016.09.019
Zaidi SF, Ahmed K, Saeed SA, et al Can diet modulate Helicobacter pylori-associated gastric pathogenesis? An evidence-based analysis. Nutr Cancer [Internet]. Taylor & Francis; 2017;69(7):979–989. Available from: https://doi.org/10.1080/01635581.2017.1359310
Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med BMC Medicine. 2017;15(1):1–11.
Enani S, Bahijri S, Malibary M, Jambi H, Eldakhakhny B, Al-Ahmadi J, Al Raddadi R, Ajabnoor G, Boraie A, Tuomilehto J. The association between dyslipidemia, dietary habits and other lifestyle indicators among non-diabetic attendees of primary health care centers in Jeddah. Saudi Arabia Nutrients. 2020;12(8):1–22.
Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 2016;66(1):6–30.
doi: 10.1136/gutjnl-2016-312288
pubmed: 27707777
Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H pylori density and distribution. Gastrointest Endosc. 1994;40(3):342–5.
doi: 10.1016/S0016-5107(94)70067-2
pubmed: 7794303
Johannes G. Kusters,* Arnoud H. M. et al. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2016;21(3):19–25